ALP AI Overview
- Headquarters
- San Diego, United States
- Website
- alpbio.ai
- Industry
- Biotechnology Research
- Employees
- 4
- Founded
- 2025
- Stock Symbol
- IN
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About ALP AI
ALP AI is pioneering immunogenicity intelligence for biologics. Our platform combines human tonsil organoids with generative AI to predict and prevent immune responses (ADAs) before clinical trials. We help drug developers de-risk pipelines and launch safer, more effective antibody therapies.
ALP AI Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
ALP AI Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Christian Vahlensieck | Co-founder in Immunogenicity - Pharma | Zurich, Switzerland |
View
|
| Anatol Ehrlich | Phd Candidate in AI - Co-founder | Vienna, Austria |
Email
|
| Lucas Schaus, Phd | Biotech Founder - Phd in Protein |
View
|
Employees by Management Level
Executive
3 profiles
Compare Similar Companies to ALP AI
HAYA Therapeutics
Biotechnology Research
BioCopy AG
Biotechnology Research
Hedera Dx
Biotechnology Research
Scailyte
Biotechnology
InVirtuoLabs
Biotechnology Research
Juvion Health Sciences
Pharmaceutical Manufacturing
Nerai Bioscience
Biotechnology Research
Aukera Therapeutics
Biotechnology Research
Moonlight AI
Technology, Information And Internet
Navis Bio
Technology, Information And Internet